Phase III Study of adjuvant chemotherapy for the patients resected pathological stage I(T1>2cm) Non Small Cell Lung Cancer (JCOG0707)
Phase 3
- Conditions
- on Small Cell Lung Cancer
- Registration Number
- JPRN-UMIN000001494
- Lead Sponsor
- Japan Clinical Oncology Group(JCOG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 960
Inclusion Criteria
Not provided
Exclusion Criteria
1) Active another neoplasm 2) severe postoperative complications 3) severe complications 4) history of severe hypersensitivity(>=Grade3) 5) Concomitant therapy with flucytocine, phenytoin or Warfarin Potassium 6) pregnant or lactating women 7) serious psychiatric illness 8) HIV positive
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method